We remain committed to the principles of responsible business conduct promoted by the United Nations Global Compact and support broader UN goals, including the Sustainable Development Goals.
The UN Global Compact principles are consistent with Novo Nordisk’s Triple Bottom Line business principle, which guides me and my colleagues’ decision-making and actions. We do business in a financially, socially and environmentally responsible way. This is an integral part of our ambition to be a sustainable business.
This 'Communication on Progress' guides readers to the sections on novonordisk.com where we account for our actions in accordance with the requirements as a participant to the UN Global Compact.
Here we present our approach to, and results within the areas of human rights, labour, environment and anti-corruption for 2018, and an update on our actions in contribution to achievement of the Sustainable Development Goals.
This information complements the contents in our integrated Annual Report.
We hope you will find it an interesting read.
Lars Fruergaard Jørgensen
President & chief executive officer
Our commitment to respect Human Rights is stated in Novo Nordisk´s Human Rights Commitment.
To evaluate our impacts on the human rights, a risk assessment process is in place.
Moreover, to mitigate the potential issues related to the human rights in our supply chains, we conduct the Responsible Sourcing Programme.
We strengthen our strategic contribution to promote the right to
health through our Changing Diabetes® programmes.
Our commitment to respect labour in the workplace is set out in our
internal guidelines. We conduct a risk assessment process to ensure
that all the forms of forced and child labour are eliminated, as well
as all the forms of discrimination, guaranteeing our employees equal
opportunities, employee representation and freedom of
To read more about our policy & governance, risk determination process, key results & KPIs, visit our Labour Rights page.
In Novo Nordisk we are committed to reduce our use of natural
resources and the environmental impact from our activities. Due to our
risk assessment procedures we are able to mitigate our impact on the
environment. In 2018 a new environmental strategy has been implemented
to enhance our commitment.
To conduct our business in a responsible way, we refer to one of our Novo Nordisk Way Guiding Principle: “we never compromise on quality and business ethics”.
Moreover, to ensure that all our actions are aligned with our
Business Ethics Code of Conduct, we adopt internal monitoring
processes, audit activities and risk management procedures.
To read more about our policy & procedures, actions and key results go to the Business ethics and anti-corruption section on our webpage or read the article Responsible Business in our Annual Report 2018.